Sonoma Biotherapeutics

Omeros Corporation is a leading biopharmaceutical company based in Seattle, WA. With a focus on innovative and cutting-edge science, their world-class team has achieved scientific breakthroughs that have led to the development of wholly new classes of therapeutics, benefiting patients with challenging diseases and disorders. Their deep and diverse pipeline of small-molecule and protein therapeutics includes first-in-class drugs with new mechanisms of action, targeting previously untapped receptors and enzymes. The Omeros team is known for being exceptionally talented, passionate, collaborative, and diverse. They are committed to hiring smart, creative, and hard-working individuals from around the world who want to make a meaningful impact in the biopharmaceutical industry. Together, they strive to provide hope to patients and their families by delivering better outcomes and life-saving therapies.Generated from the website

Universal Cells Inc, based in Seattle, WA, is a pioneering company specializing in the creation of engineered, allogeneic stem cells that can be differentiated into various therapeutic cell types. Utilizing nuclease-free, recombinant Adeno-Associated Virus rAAV gene editing technology, Universal Cells aims to develop universal donor, pluripotent stem cells for the advancement of cell therapy. With a focus on editing genes essential for immune recognition, Universal Cells is at the forefront of innovation in producing off-the-shelf, stem cell-based products. The company's dedicated teams work on a range of programs from basic discovery to product development, striving to revolutionize the field of regenerative medicine through cutting-edge gene editing methods and stem cell engineering.Generated from the website

Actx Inc, based in Seattle, WA, offers genomic services and personalized user experiences through their website. Users can access and use the services by accepting the terms of service, which outline legal rights and obligations. The company provides a non-exclusive license to access and use their materials, including data, software, and information, while also emphasizing the importance of privacy and feedback. Actx reserves the right to modify terms and conditions, requiring users to review and accept any changes to continue using their services.Generated from the website